Paul Gaynon, MD

Attending Physician; Hematology, Oncology and Blood and Marrow Transplantation
Professor of Pediatrics, Keck School of Medicine of USC

Education

Medical School

University of Illinois College of Medicine

Internship

Stanford University Program: Pediatrics

Residency

Stanford University Program: Pediatrics

Fellowship

Children's Memorial Hospital/Chicago: Pediatrics Hematology/Oncology

Accomplishments

Certification

Pediatrics: American Board of Pediatrics; Pediatric Hematology-Oncology: American Board of Pediatrics

Publications

Research

New Agents and Childhood Acute LyMPHoblastic Leukemia (ALL)

Research Studies

This study is testing a new experimental drug Temisirolimus - Temsirolimus (also known as Torisel®) is approved for kidney cell cancer treatment in adults - in combination with approved chemotherapy drugs - in the hopes of finding a drug combination that may be effective against leukemia and non-hodgkin’s lymphoma that has come back after initial treatment.